
Abstract 2769: PET imaging shows dose-dependent pharmacokinetics of a 89Zr-labeled mesothelin/CD3 half-life extended bispecific T-cell engager molecule in a syngeneic mouse model
Author(s) -
Frans V. Suurs,
Grit Lorenczewski,
Julie M. Bailis,
Sabine Stienen,
Matthias Friedrich,
Elisabeth G.E. de Vries,
Derk Jan de Groot,
Marjolijn N. Lub-de Hooge
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-2769
Subject(s) - biodistribution , nuclear medicine , mesothelin , medicine , cd3 , pharmacokinetics , positron emission tomography , cancer , cancer research , immune system , chemistry , microbiology and biotechnology , biology , pharmacology , immunology , cd8 , in vitro , biochemistry